PB1829: ARGENTINEAN REAL WORLD EXPERIENCE ON MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VS INTENSIVE CHEMOTHERAPY TO TREAT FLT3 POSITIVE ACUTE MYELOID LEUKEMIA PATIENTS. (23rd June 2022) - Navickas, A.; González, J.; Rivas, M. M.; Clavijo, M.; Carnelutto, N.; Funes, M. E.; Mela Osorio, M. J.; Mariano, R.; Rapan, M. L.; Moirano, M.; Rey, I.; Cranco, S.; et al.